The increase in IL‐6 induced by radiation may be related to tumour regrowth. Therefore, clinical treatment with IL‐6 inhibitors may be a potential treatment strategy to induce NSCLC sensitivity to radiation.38 Here, IL6 is linked to neoplasm.